Skip to main content
. 2023 Apr 16;12(11):12325–12335. doi: 10.1002/cam4.5931

FIGURE 3.

FIGURE 3

Profiles related to OR in HCC patients treated with Atez/Bev. Decision‐tree algorithm for OR. The pie graphs indicate the percentage of OR (white)/non‐OR (black) in each group. Atez/Bev, atezolizumab plus bevacizumab; HCC, hepatocellular carcinoma; OR, objective response.